CorMedix
CRMD
S$14.99
Share price
-2.84%
Change (1 day)
138.65%
Change (1 year)
Categories
Revenue for CorMedix (CRMD)
Revenue in 2025 (TTM): S$0.11 Billion
According to CorMedix's latest financial reports the company's current revenue (TTM 
) is S$0.10 Billion. In 2024 the company made a revenue of S$59.09 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CorMedix from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | S$0.11 B | 87.4% |
| 2024 | S$59.09 M | |
| 2023 | N/A | -100% |
| 2022 | S$0.08 M | -66.03% |
| 2021 | S$0.25 M | -18.44% |
| 2020 | S$0.31 M | -17.13% |
| 2019 | S$0.38 M | -34.96% |
| 2018 | S$0.58 M | 33.3% |
| 2017 | S$0.44 M | 35.8% |
| 2016 | S$0.32 M | 9.12% |
| 2015 | S$0.29 M | 18.85% |
| 2014 | S$0.25 M | 9764.81% |
| 2013 | S$0 M | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | S$26.86 B | 25,176.84% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | S$1.19 B | 1,026.90% | 🇺🇸 USA |
 Utah Medical Products UTMD | S$50.56 M | -52.43% | 🇺🇸 USA |